Biotech

All Articles

Lilly, Haya ink $1B biobuck being overweight deal to explore black genome

.Eli Lilly's look for excessive weight targets has actually led it to the black genome. The Big Phar...

ArsenalBio increases $325M, turns out of former lead resource

.Collection Biosciences is actually moving on up. The cell therapy business has actually added on $3...

Lilly- supported effective weight loss biotech documents IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has actually...

Aelis' cannabis usage drug flunks period 2b, steering Indivior to re-think $100M choice

.Aelis Farma's hopes of securing a fast, good decision on a $100 million option payment have actuall...

ProKidney halts period 3 trial not needed to have for tissue therapy confirmation

.ProKidney has ceased one of a set of stage 3 tests for its own tissue therapy for kidney illness af...

Vaxcyte surges on 'impressive' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals called "impressive" stage 1/2 data for its 31-valent pneumococc...

Recursion's brain condition trial shows little documentation of effectiveness

.Recursion has actually stumbled via a very early exam of its tech-enabled technique to medicine exp...

Acepodia, Pfizer click on together for chemistry-based cell treatment

.Call it a scenario of really good chemical make up: Acepodia, a biotech based upon Nobel Champion s...

Praxis epilepsy drug lowers seizures in period 2 trial

.Praxis Preciseness Medicines has actually scored one more midphase gain in epilepsy this year, with...

Three execs resign as Dyne posts combined information for DMD applicant

.After escaping a professional hold a number of years back, Dyne Therapy has revealed brand new peri...